Pancreatic Cancer Research

ResearcherOkayama UniversityNo recent work listed

Kazuhide Yamamoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5108401253. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 12)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 3 papers · 2014: 2 papers · 2015: 3 papers · 2016: 2 papers · 2017: none · 2018: 1 paper

Papers 14

  1. Impact of Body Mass Index on Survival of Pancreatic Cancer Patients in Japan. Last author DOI 10.18926/amo/55853↗
  2. Synergistic anti-pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells/dickkopf-3 protein and peripheral blood mon… Last author DOI 10.1111/jgh.13259↗
  3. Chemotherapy-induced Nausea and Vomiting in Patients with Hepatobiliary and Pancreatic Cancer Treated with Chemotherapy: A Prospective Observational Study by t… Co-author PMID 27069182↗
  4. Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer. Last author DOI 10.1002/cncr.29364↗
  5. Prognostic value of altered N-glycosylation of circulating glycoproteins in patients with unresectable pancreatic cancer treated with gemcitabine. Last author DOI 10.1097/mpa.0000000000000321↗
  6. Serum anti-60S ribosomal protein L29 antibody as a novel prognostic marker for unresectable pancreatic cancer. Last author DOI 10.1159/000371545↗
  7. Corrigendum to “Loss of runt‐related transcription factor 3 induces gemcitabine resistance in pancreatic cancer” [Mol. Oncol. 7 (2013) 840–849] Last author DOI 10.1016/j.molonc.2014.03.007↗
  8. Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer. Last author DOI 10.1111/jgh.12501↗
  9. Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer. Last author DOI 10.1007/s00535-012-0732-7↗
  10. Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer. Last author DOI 10.1016/j.molonc.2013.04.004↗
  11. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and de… Co-author DOI 10.1097/mpa.0b013e3182550d77↗
  12. Monitoring of CA19-9 and SPan-1 can facilitate the earlier confirmation of progressing pancreatic cancer during chemotherapy. Last author DOI 10.1016/j.pan.2012.07.009↗
  13. A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensit… Last author DOI 10.1007/s10147-011-0237-z↗
  14. Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients. Last author DOI 10.1159/000330384↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hironari Kato · 11 shared papers, 2011–2016 · strength 0.41
  2. Kazuhiro Nouso · 8 shared papers, 2012–2016 · strength 0.29
  3. Koichiro Tsutsumi · 6 shared papers, 2011–2015 · strength 0.23
  4. Shigeru Horiguchi · 4 shared papers, 2013–2016 · strength 0.15
  5. Koji Miyahara · 3 shared papers, 2013–2015 · strength 0.11
  6. Hideaki Kinugasa · 2 shared papers, 2015 · strength 0.09
  7. Daisuke Uchida · 2 shared papers, 2014–2016 · strength 0.09
  8. Tetsushige Mimura · 1 shared paper, 2018 · strength 0.08
  9. Tomohiro Okura · 1 shared paper, 2018 · strength 0.08
  10. Hiroyuki Okada · 2 shared papers, 2012–2015 · strength 0.07
  11. Hirofumi Kawamoto · 3 shared papers, 2011–2012 · strength 0.07
  12. Shin‐Ichiro Nishimura · 2 shared papers, 2013–2015 · strength 0.07
  13. Shinichiro Muro · 1 shared paper, 2015 · strength 0.06
  14. Shinichi Ohkawa · 1 shared paper, 2016 · strength 0.06
  15. Mototsugu Shimokawa · 1 shared paper, 2016 · strength 0.06
  16. Hironobu Minami · 1 shared paper, 2016 · strength 0.06
  17. Hidetoshi Nitta · 1 shared paper, 2016 · strength 0.06
  18. Go Wakabayashi · 1 shared paper, 2016 · strength 0.06
  19. Junji Furuse · 1 shared paper, 2016 · strength 0.06
  20. Hideo Baba · 1 shared paper, 2016 · strength 0.06
  21. Hiroaki Sawahara · 1 shared paper, 2016 · strength 0.05
  22. Ken Hirao · 2 shared papers, 2011–2012 · strength 0.05
  23. Akinori Asagi · 1 shared paper, 2013 · strength 0.03
  24. Haruo Iguchi · 1 shared paper, 2013 · strength 0.03
  25. Kazuyuki Matsumoto · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.